| Aug 4 2020 |
EPA Awards $4 Million to Develop New Approaches for Evaluating Chemical Toxicokinetics |
Bergeson & Campbell, P.C. |
| Aug 3 2020 |
COVID-19 Brings Consumer Convenience to Pennsylvania |
Norris McLaughlin P.A. |
| Aug 3 2020 |
FDA Issues Long-Awaited Draft Guidance on Cannabis Research |
McDermott Will & Schulte LLP |
| Aug 3 2020 |
FDA Releases a New EPA-Approved Protocol for Evaluating the Efficacy of Antimicrobial Pesticides in Agricultural Water |
Keller and Heckman LLP |
| Jul 31 2020 |
McDermottPlus Check-Up: July 31, 2020 |
McDermott Will & Schulte LLP |
| Jul 31 2020 |
EPA Announces the Approval of 13 Additional Products Effective against SARS-CoV-2 |
Bergeson & Campbell, P.C. |
| Jul 30 2020 |
FDA Sends Warning Letters to Companies Illegally Selling Hangover Supplements |
Keller and Heckman LLP |
| Jul 30 2020 |
Coronavirus Innovation Guideposts on the Eve of the COVID-19 Pandemic |
Foley & Lardner LLP |
| Jul 30 2020 |
Pizza Boxes Are Recyclable, According to New Study |
Keller and Heckman LLP |
| Jul 29 2020 |
August 13, 2020 Deadline for Healthcare Providers and Life Sciences Federal Contractors: Ban on Use of Certain Chinese Telecommunications Equipment and Services |
McDermott Will & Schulte LLP |
| Jul 29 2020 |
US House Appropriates $3.2 Billion for FDA for Fiscal Year 2021 |
Keller and Heckman LLP |
| Jul 29 2020 |
New York Legislature Passes Bill to Ban PFAS in Food Packaging |
Keller and Heckman LLP |
| Jul 28 2020 |
FDA Issues Draft Guidance on Cannabis Clinical Research and Sends CBD Enforcement Discretion Guidance to OMB for Review |
Epstein Becker & Green, P.C. |
| Jul 28 2020 |
Florida Supreme Court Requests Additional Oral Argument in Major Medical Marijuana Licensure Case |
Greenberg Traurig, LLP |
| Jul 28 2020 |
Japan Proposes Revisions to Positive List for Food-Contact Resins |
Keller and Heckman LLP |
| Jul 28 2020 |
CBD: Sometimes It Can Be Legal but Still “Unlawful” |
Squire Patton Boggs (US) LLP |
| Jul 27 2020 |
President Trump Signs Drug Pricing Executive Orders Reinforcing the Administration's Priorities |
K&L Gates LLP |
| Jul 27 2020 |
A Shot Across the Bow of the Pharmaceutical Industry: President Trump Issues a Quartet of Executive Orders on Drug Pricing that Might Eventually (OR NEVER?) Take Effect |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 27 2020 |
COVID-19 Food & Beverage Regulatory Updates |
Foley & Lardner LLP |
| Jul 27 2020 |
In Response to COVID-19, FDA Extends Enforcement Discretion for HCT/Ps Requiring Pre-Market Review |
Epstein Becker & Green, P.C. |
| Jul 27 2020 |
AMS Proposes to Add “Sugarcane (Insect Resistant)” to the List of Bioengineered Foods Subject to Disclosure Under the National Bioengineered Food Disclosure Standard |
Keller and Heckman LLP |
| Jul 25 2020 |
Trump Administration Releases Series of Executive Orders on Drug Pricing |
Mintz |
| Jul 24 2020 |
Sixth Circuit Panel Dismisses Motion to Enforce Writ of Mandamus |
Squire Patton Boggs (US) LLP |
| Jul 24 2020 |
No “White” Lie: Plaintiffs Fail to Show Reasonable Consumer Would Expect “White Morsels” to Contain White Chocolate |
Proskauer Rose LLP |
| Jul 24 2020 |
Can Percentages be Rounded in Relative Nutrient Content Claims? |
Keller and Heckman LLP |
| Jul 24 2020 |
FDA Issues Final Compliance Policy Guide on the Use of The Seafood List to Determine Acceptable Seafood Names |
Keller and Heckman LLP |
| Jul 23 2020 |
COVID-19: FDA Clears Path for Test to Screen Asymptomatic Individuals |
Foley & Lardner LLP |
| Jul 23 2020 |
FDA Announces Qualified Health Claim for Certain Cranberry Products and Urinary Tract Infections |
Keller and Heckman LLP |
| Jul 23 2020 |
A Legen-dairy Victory: Ben & Jerry’s Wins “Happy Cows” False Advertising Lawsuit |
Proskauer Rose LLP |
| Jul 23 2020 |
K&L Gates Triage: Recent Developments in the 340B Drug Pricing Program [Podcast] |
K&L Gates LLP |
| Jul 22 2020 |
Ohio Case Will Likely Determine Whether Other States Use 21st Amendment Enforcement Act |
McDermott Will & Schulte LLP |
| Jul 22 2020 |
New FDA Draft Guidance Clarifies Cannabis-Related Clinical Research Requirements |
Keller and Heckman LLP |
| Jul 21 2020 |
Senators Announce Bipartisan Bill Requiring Pharmaceutical Supply Chain Report |
Squire Patton Boggs (US) LLP |
| Jul 21 2020 |
340b Update: HRSA Indicates It Lacks Authority to Enforce 340b Program Guidance |
K&L Gates LLP |
| Jul 21 2020 |
Elmiron Litigation Continues: What they still aren’t telling you… |
Stark & Stark |
